Llwytho...
Efficacy of palifermin (keratinocyte growth factor-1) in the amelioration of oral mucositis
PURPOSE: Oral mucositis is a significant toxicity of cytotoxic chemo- and radiation-therapy used to treat cancer. Palifermin is the first pharmaceutical/biological agent approved for the intervention of oral mucositis. The major objective of this review is to evaluate the evidence supporting the use...
Wedi'i Gadw mewn:
Prif Awdur: | |
---|---|
Fformat: | Artigo |
Iaith: | Inglês |
Cyhoeddwyd: |
Dove Medical Press
2010
|
Pynciau: | |
Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2899789/ https://ncbi.nlm.nih.gov/pubmed/20694076 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|